Finance

Novo Nordisk stock surges 7% after Ozempic maker’s latest weight-loss drug shows promise

admin 




The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger. Read More



Source link

Recommended Posts

Finance

The dark history behind the executive to-do list

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal InformationFORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive […]

admin